These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bevacizumab in glioblastoma--still much to learn. Fine HA N Engl J Med; 2014 Feb; 370(8):764-5. PubMed ID: 24552324 [No Abstract] [Full Text] [Related]
5. Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma? Desjardins A Nat Rev Neurol; 2015 Aug; 11(8):429-30. PubMed ID: 26195258 [No Abstract] [Full Text] [Related]
6. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. Chinot OL; Wick W; Mason W; Henriksson R; Saran F; Nishikawa R; Carpentier AF; Hoang-Xuan K; Kavan P; Cernea D; Brandes AA; Hilton M; Abrey L; Cloughesy T N Engl J Med; 2014 Feb; 370(8):709-22. PubMed ID: 24552318 [TBL] [Abstract][Full Text] [Related]
7. Potential novel role of bevacizumab in glioblastoma and cervical cancer. Goey AK; Figg WD Cancer Biol Ther; 2014 Oct; 15(10):1296-8. PubMed ID: 25046485 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma. Lou E; Peters KB; Sumrall AL; Desjardins A; Reardon DA; Lipp ES; Herndon JE; Coan A; Bailey L; Turner S; Friedman HS; Vredenburgh JJ Cancer Med; 2013 Apr; 2(2):185-95. PubMed ID: 23634286 [TBL] [Abstract][Full Text] [Related]
15. Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma. Hainsworth JD; Shih KC; Shepard GC; Tillinghast GW; Brinker BT; Spigel DR Clin Adv Hematol Oncol; 2012 Apr; 10(4):240-6. PubMed ID: 22706484 [TBL] [Abstract][Full Text] [Related]
16. Bevacizumab as secondline treatment of glioblastoma - worth the effort? Rovere RK Klin Onkol; 2014; 27(3):219-20. PubMed ID: 24918282 [TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic therapy for high-grade glioma. Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542 [TBL] [Abstract][Full Text] [Related]
19. Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target. Stupp R; Weller M Neuro Oncol; 2014 Jun; 16(6):765-7. PubMed ID: 24826844 [No Abstract] [Full Text] [Related]
20. Is deferred use of bevacizumab for glioblastoma associated with prolonged survival? D'Alessandris QG; Capo G; Pallini R Neuro Oncol; 2014 Oct; 16(10):1427. PubMed ID: 25053854 [No Abstract] [Full Text] [Related] [Next] [New Search]